Why Lilly and Novo Nordisk will continue to dominate the blockbuster GLP-1 drug market

Why Lilly and Novo Nordisk will continue to dominate the blockbuster GLP-1 drug market

One in eight American adults say they have tried a GLP-1 drug, according to a recent survey. getty meIt’s not often that a class of chemicals becomes a household name, …

Read more

Bernie Sanders calls on Ozempic maker Novo Nordisk to be fair on outrageously high US drug prices

Bernie Sanders calls on Ozempic maker Novo Nordisk to be fair on outrageously high US drug prices

top line Bernie Sanders has urged Denmark to take control of its most valuable company, Novo Nordisk, and force it to cut prices on popular weight loss and diabetes treatments …

Read more

Roger S. McIntyre, MD: GLP-1 agonists for psychiatry?

Roger S. McIntyre, MD: GLP-1 agonists for psychiatry?

GLP-1/GIP receptor agonists, including semaglutide (Ozempic) and the investigational retatrutide, represent a seismic shift in cardiometabolic and comorbidity treatment. Over the past decade, the emerging drug class has been robustly …

Read more